glp-1 and naion The Effect of Semaglutide RAs on Risk of Nonarteritic Anterior Ischemic Optic Neuropathy Semaglutide NAION Network Study Announcement

[DOI] [PMC free article] [PubMed] [Google Scholar] 2.GBD Chronic Kidney Disease Collaboration Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017

While Ozempic and Wegovy primarily focus on GLP-1 receptor activation, Mounjaros dual action provides a broader approach to managing blood sugar levels Mounjaro is particularly beneficial for adults with type 2 diabetes patients

However, this approach lacks official recommendations and has not undergone thorough clinical testing to ensure its safety and effectiveness

1), S152S158

All authors have read and agreed to the published version of the manuscript

Understanding the difference between convenience and biological plausibility is essential before trusting any GLP-1 patch claim